Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-04-13 @ 8:16 AM
Study NCT ID:
NCT06984094
Status:
RECRUITING
Last Update Posted:
2025-08-08
First Post:
2025-05-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults
Sponsor:
Clover Biopharmaceuticals AUS Pty
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CLO-SCB-1033-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None